Skip to content

SRZN

Surrozen, Inc./DE

NASDAQ · Healthcare · Biotechnology · US

$31.65
+5.08%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
111.88x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
-1.70x
Price / sales
32.32x
Price / cash flow
-10.70x

Enterprise value

Enterprise value
$276.3M
EV / sales
24.00x
EV / EBITDA
-0.83x
EV / EBIT
-6.23x
Market cap
$372.0M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026